Skip to Content
Merck
  • Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.

Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.

Archiv der Pharmazie (2013-07-25)
Mehlika D Altıntop, A Selen Gurkan-Alp, Yusuf Ozkay, Zafer A Kaplancıklı
ABSTRACT

In the present paper, a novel series of dithiocarbamates was synthesized via the treatment of 4-(trifluoromethyl)benzyl chloride with appropriate sodium salts of N,N-disubstituted dithiocarbamic acids. The chemical structures of the compounds were elucidated by (1) H NMR, mass spectral data, and elemental analyses. Each derivative was evaluated for its ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) using a modification of Ellman's spectrophotometric method. The most potent AChE inhibitor was found as compound 2g (IC50  = 0.53 ± 0.001 µM) followed by compounds 2f (IC50  = 0.74 ± 0.001 µM) and 2j (IC50  = 0.89 ± 0.002 µM) when compared with donepezil (IC50  = 0.048 ± 0.001 µM). Compounds 2f and 2g were more effective than donepezil (IC50  = 7.88 ± 0.52 µM) on BuChE inhibition. Compounds 2f and 2g exhibited the inhibitory effect on BuChE with IC50 values of 1.39 ± 0.041 and 3.64 ± 0.072 µM, respectively.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3-(Trifluoromethyl)benzyl chloride, 97%
Sigma-Aldrich
4-(Trifluoromethyl)benzyl chloride, 98%